Schroder Investment Management Group
ADVM

Schroder Investment Management Group’s Adverum Biotechnologies ADVM Stock Holding History

Schroder Investment Management Group’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,146
Closed -$350K – 1320
2017
Q3 		$350K Sell
10,146
-948
-9% -$26.3K ﹤0.01% 1127
2017
Q2 		$278K Hold
11,094
– – ﹤0.01% 1129
2017
Q1 		$300K Hold
11,094
– – ﹤0.01% 1075
2016
Q4 		$322K Hold
11,094
– – ﹤0.01% 1002
2016
Q3 		$456K Hold
11,094
– – ﹤0.01% 982
2016
Q2 		$351K Buy
+11,094
New +$501K ﹤0.01% 991

Other funds holding ADVM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Schroder Investment Management Group's ADVM Position: Q4 2017 in Review

Schroder Investment Management Group sold out of Adverum Biotechnologies (ADVM) in Q4 2017, closing a stake of 10,146 shares — an estimated $350K sold.

Schroder Investment Management Group first reported a position in ADVM in Q2 2016 and held it in 6 quarters. The position peaked at $456K in Q3 2016. 65 funds tracked by Wall St. Rank hold ADVM as of Q4 2017.

  • Schroder Investment Management Group reported no remaining Adverum Biotechnologies position as of Q4 2017 after selling out during the quarter.
  • Schroder Investment Management Group sold 10,146 Adverum Biotechnologies shares in Q4 2017, an estimated $350K.
  • Schroder Investment Management Group first reported a position in Adverum Biotechnologies in Q2 2016 and held it in 6 quarters.
  • Schroder Investment Management Group's Adverum Biotechnologies position peaked at $456K in Q3 2016.
  • 65 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2017.

Based on Schroder Investment Management Group's 13F filing for Q4 2017, filed 9 Feb 2018.